LumiraDx Inc: LumiraDx Reports Second Quarter 2022 Results

Strong Pipeline Progress and Commercialization Priorities for Newly Authorized ProductsLONDON, Aug. 18, 2022 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX), a next-generation point of care (POC) diagnostics

Related Keywords

United Kingdom ,London ,City Of ,Ron Zwanziger ,Colleen Mcmillen ,Exchange Commission ,Fast Lab Solution ,Movement In Cash ,Lumiradx Limited Nasdaq ,Melinda Gates Foundation ,Strong Pipeline Progress ,Commercialization Priorities ,Newly Authorized ,Ultra Pool ,Lumiradx Chairman ,Quarter Financial ,Lumiradx Platform ,Securities Litigation Reform Act ,Annual Report ,Consolidated Statement ,Ordinary Shares ,Cash Equivalents ,Lumiradx ,Reports ,Second ,Quarter ,022 ,Results ,